EXHIBIT 31.1

                                 CERTIFICATION

  I, Howard G. Berger, M.D., certify that:

  1.   I have reviewed this quarterly report on Form 10-Q of Primedex Health
       Systems, Inc.

  2.   Based on my knowledge, this quarterly report does not contain any untrue
       statement of a material fact or omit to state a material fact necessary
       to make the statements made, in light of the circumstances under which
       such statements were made, not misleading with respect to the period
       covered by this quarterly report.

  3.   Based on my knowledge, the financial statements, and other financial
       information included in this quarterly report, fairly present in all
       material respects the financial condition, results of operations and cash
       flows of the registrant as of, and for, the periods presented in this
       quarterly report;

  4.   I am responsible for establishing and maintaining disclosure controls and
       procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
       registrant and have:
       a.   designed such disclosure controls and procedures, or caused such
            disclosure controls and procedures to be designed under my
            supervision, to ensure that material information relating to the
            registrant, including its consolidated subsidiaries, is made known
            to me by others within those entities, particularly during the
            period in which this report is being prepared;
       b.   evaluated the effectiveness of the registrant's disclosure controls
            and procedures and presented in this report my conclusions about the
            effectiveness of the disclosure controls and procedures, as of the
            end of the period covered by this report based on such evaluation;
            and
       c.   disclosed in this report any change in the registrant's internal
            control over financial reporting that occurred during the
            registrant's most recent fiscal quarter that has materially
            affected, or is reasonably likely to materially affect, the
            registrant's internal control over financial reporting.

  5.   I have disclosed, based on my most recent evaluation of internal control
       over financial reporting, to the registrant's auditors and the audit
       committee of the registrant's board of directors (or persons performing
       the equivalent functions):
       a.   all significant deficiencies and material weaknesses in the design
            or operation of internal control over financial reporting which are
            reasonably likely to adversely affect the registrant's ability to
            record, process, summarize and report financial information; and
       b.   any fraud, whether or not material, that involves management or
            other employees who have a significant role in the registrant's
            internal control over financial reporting.

Dated: June 11, 2004

                                              /s/ HOWARD G. BERGER, M.D.
                                              ----------------------------------
                                              Howard G. Berger, M.D., Chairman,
                                              President, Chief Executive Officer
                                              and Chief Financial Officer